Clinical Trial Update: FDHT PET and Bicalutamide in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FDHT PET imaging and bicalutamide in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• bicalutamide (bicalutamide)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED